Track

What to watch.

Dated moves across Singapore and Australia longevity: results, milestones, and regulatory decisions. Every entry sourced.

Upcoming

No confirmed events in the near term. The record below tracks dated moves across both markets.

Recent

June 2026

Everlab closes an AU$65M Series A16 Jun 2026
Australia
Led by AirTree Ventures; total raised reaches roughly AU$80M, with the UK named as the next market.

April 2026

PROMETHEUS advances to the XPRIZE Healthspan finals15 Apr 2026
Trial milestone · Singapore
The NUS Academy PROMETHEUS trial reached the XPRIZE Healthspan finals (month confirmed, exact date not published).
FDA approves oral orforglipron (Foundayo)1 Apr 2026
Regulatory · Global
The first oral GLP-1 receptor agonist to clear the FDA.

December 2025

Insilico Medicine lists on the Hong Kong Stock Exchange30 Dec 2025
Global
HK$2.28B raised (HKEX:3696), the largest 2025 Hong Kong biotech listing; Temasek held a cornerstone position.
FDA approves oral semaglutide (Wegovy)6 Dec 2025
Regulatory · Global
Oral semaglutide cleared by the FDA; commercial launch followed in January 2026.